Researchers at the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health and the University of New South Wales, Sydney, Australia, provide new evidence supporting an association between elevated levels of enteroviruses in the intestinal tracts of children and islet autoimmunity, a precursor to Type 1 diabetes. The paper appears in the journal Scientific Reports.
Approximately 40,000 cases of Type 1diabetes are diagnosed each year in the U.S. In Australia, where the study cohort originated, almost 60 percent of newly diagnosed cases are in children and people younger than 25 years.
Researchers examined blood and feces collected from 93 children as part of the Australian Viruses In the Genetically at Risk study (VIGR), a prospective birth cohort of children with at least one first-degree relative with Type 1 diabetes. The study used Virome-Capture-Sequencing for Vertebrate-infecting viruses (VirCapSeq-VERT), a viral sequencing tool developed at the CII that is up to 10,000 times more powerful at identifying viruses than conventional high-throughput (next generation) sequencing methods.
A test of fecal samples found 129 viruses that were more abundant in the guts of children with islet autoimmunity versus age and gender-matched controls, including five enterovirus-A viruses significantly more abundant in cases. The enterovirus A species includes viruses that are the source of common infant infections such as hand, foot and mouth disease, but also encephalitis; in most cases, however, infections are asymptomatic or mild. Researchers say further study is needed to pinpoint the specific virus or viruses that can lead to islet autoimmunity and Type 1 diabetes.
Blood samples did not show an association between enteroviruses and islet autoimmunity, a finding the researchers say is in keeping with the fact that the body clears viruses from the bloodstream more quickly than from the gut.
“These findings strengthen the model that enteroviruses can spread from the gut into a child’s pancreas and trigger autoimmunity in the cells that regulate blood sugar,” says Thomas Briese, PhD, associate professor of Epidemiology and CII lead on the project. “Knowing the virus types involved is a critical step toward developing new strategies for prevention and treatment of Type 1 diabetes.”
###
The study’s first author is Ki Wook Kim of the University of New South Wales. Co-authors include Jessica L. Horton, Chi Nam Ignatius Pang, Sonia R. Isaacs, William D. Rawlinson, Maria E. Craig, Preston Leung, Rowena A. Bull, Fabio Luciani, and Marc R.Wilkins, also of the University of New South Wales; Jacki Catteau, Children’s Hospital at Westmead, Sydney, Australia; and Komal Jain , W. Ian Lipkin, and Thomas Briese of the CII at Columbia’s Mailman School of Public Health.
The study was supported by the Diabetes Australia Research Grant, Rebecca L. Cooper Medical Research Grant, Australian National Health and Medical Research Council, Practitioner Fellowship, and the U.S. National Institutes of Health (Center for Research in Diagnostics and Discovery, U19AI109761). The authors declare no competing interests.
About VirCapSeq-VERT
VirCapSeq-VERT, a streamlined version of unbiased sequencing, references a library of sequences selected from among approximately 2 million genetic pieces, representing all viral taxa known to infect vertebrates. These genetic pieces are used to constitute a probe, which is mixed with the material taken from the sample being tested. Magnetic beads are then used to “pull out” the segments from the sample that match the probe; only these segments are finally analyzed using high-throughput sequencing. A 2015 study reported that the method resulted in 100 to 10,000-fold increases in viral matches compared with conventional high-throughput tests. The test has been used in studies of Chikungunya in Brazil, respiratory disease in Uganda, and unexplained illness in Tanzania.
Media Contact
Tim Paul
[email protected]
212-305-2676
http://dx.
